ARTICLE
14 October 2019

Defendant And His Companies Ordered To Pay Over $2 Million In A Theft Of Trade Secrets Case

WT
Winston Taylor

Contributor

Whether you're leading the way, disrupting an industry, entering a new phase of growth, or launching a defining product—we're in the room with you. In the action. Sleeves rolled up.

With a rich history spanning both sides of the Atlantic, we are present in the major commercial centers that matter to our clients: the U.S., the U.K., Europe, Latin America, and the Middle East. Combining scale with the speed clients demand, our defining capabilities include major litigation, critical transactions, strategic IP, and private wealth.

Our team of over 1,400 lawyers works hand-in-hand across markets, sectors, practice areas, and client teams. All-in problem solvers, we bring the creativity to think differently, and the pragmatism to get things done when it counts the most.

Embedded in your business and sharing your ambition, we take the work personally. Shaping what we do and how we do it around your goals and needs, always one step ahead of the moment.

On September 23, 2019, Colorado District Judge Christine M. Arguello found Thomas Kutrubes and his companies, Peak Serum, Inc. and Peak Serum, LLC, liable for federal trademark infringement ...
United States Intellectual Property

On September 23, 2019, Colorado District Judge Christine M. Arguello found Thomas Kutrubes and his companies, Peak Serum, Inc. and Peak Serum, LLC, liable for federal trademark infringement, Colorado trademark infringement, misappropriation of trade secrets under the Colorado Uniform Trade Secrets Act (CUTSA), and breach of fiduciary duty, following a bench trial. Atlas Biologicals, Inc. v. Kutrubes, No. 15-cv-355-CMA-KMT, 2019 WL 4594274, at *23 (D. Colo. Sept. 23, 2019). Final judgment was entered against Mr. Kutrubes and his company for over two million dollars. Id.

Defendant Kutrubes was an employee, partial owner, and member of the Board of Directors for Atlas Biologicals, Inc., a company specializing in the production of bovine serum. Bovine serum is a byproduct of cow blood used in scientific research. The Court found that in 2014, Kutrubes created companies to compete with Atlas (while still working for Atlas) and began emailing himself important Atlas documents and trade secret information including customer contact lists, a supplier agreement, the quality manual, an organizational chart, and other key business items. He then began falsely representing to Atlas's customers that his new company (Peak Serum) and Atlas were "sister companies" and that Peak Serum would be "assuming Atlas's international customers." Shortly thereafter, Kutrubes resigned from Atlas and Atlas discovered that he had been using his work email address to "send numerous company documents to his personal Gmail account and to extensively email Atlas's customers to solicit business for [his companies]." Id. at *3. Atlas took action: it filed a complaint against Kutrubes and his companies and then filed a motion for immediate injunctive relief. The Court entered a preliminary injunction, enjoining the Defendant from using Atlas' trademarks and trade names and from further disclosing its proprietary information and trade secrets.

The parties engaged in a bench trial in March 2018. Judge Arguello found for Atlas on all claims except for conversion and civil theft, which were denied because "Atlas ha[d] not proven...that [Defendants] intended to permanently deprive Atlas of the benefit of its documents and information contained therein." Id. at *18. The Court awarded Atlas a permanent injunction, damages in the amount of $2,048,180.50, and the ability to file a motion for attorneys' fees within 30 days because the theft of trade secrets was "willful and wanton."

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

[View Source]

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More